Literature DB >> 6445348

Chronic propranolol treatment blunts right ventricular hypertrophy in rats at high altitude.

N F Voelkel, I F McMurtry, J T Reeves.   

Abstract

Chronic beta-receptor blockade has been reported to inhibit right ventricular hypertrophy in rats at high altitude. If so, we wanted to determine whether beta-receptor blockade or some other drug action were involved and whether the heart, the lung vessels, or blood alterations were affected. In rats, chronic treatment with DL-propranolol (2 mg/kg ip once daily) reduced right ventricular hypertrophy and polycythemia of chronic high altitude. D-Propranolol and metoprolol did not reduce hypoxia-induced right ventricular hypertrophy or polycythemia. In isolated lungs from low-altitude rats treated chronically with DL-propranolol or with D-propranolol the pressor response to acute hypoxia was blunted. Chronic DL-propranolol blunted the acute hypoxic pressor response and angiotensin II induced vasoconstriction in lungs from high-altitude rats. Two effects of DL-propranolol treatment were seen: 1) blockade of beta 2-adrenergic receptors, which reduced the right ventricular hypertrophy of high altitude through reduction of hematocrit; and 2) a non-beta-effect, which reduced vascular responsiveness to acute hypoxia in the isolated lung preparation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6445348     DOI: 10.1152/jappl.1980.48.3.473

Source DB:  PubMed          Journal:  J Appl Physiol Respir Environ Exerc Physiol        ISSN: 0161-7567


  8 in total

Review 1.  The adrenergic system in pulmonary arterial hypertension: bench to bedside (2013 Grover Conference series).

Authors:  Michael R Bristow; Robert A Quaife
Journal:  Pulm Circ       Date:  2015-09       Impact factor: 3.017

Review 2.  Neurohormonal activation and pharmacological inhibition in pulmonary arterial hypertension and related right ventricular failure.

Authors:  Pietro Ameri; Edoardo Bertero; Giovanni Meliota; Martino Cheli; Marco Canepa; Claudio Brunelli; Manrico Balbi
Journal:  Heart Fail Rev       Date:  2016-09       Impact factor: 4.214

Review 3.  Pulmonary hypertension.

Authors:  J R Michael; W R Summer
Journal:  Lung       Date:  1985       Impact factor: 2.584

Review 4.  Emerging Concepts in the Molecular Basis of Pulmonary Arterial Hypertension: Part II: Neurohormonal Signaling Contributes to the Pulmonary Vascular and Right Ventricular Pathophenotype of Pulmonary Arterial Hypertension.

Authors:  Bradley A Maron; Jane A Leopold
Journal:  Circulation       Date:  2015-06-09       Impact factor: 29.690

5.  The effect of isoproterenol on the development and recovery of hypoxic pulmonary hypertension. A structural and hemodynamic study.

Authors:  R Fried; L M Reid
Journal:  Am J Pathol       Date:  1985-10       Impact factor: 4.307

6.  Reduction by beta-adrenoceptor blockade of hypoxia-induced right heart hypertrophy in the rat.

Authors:  I Ostman-Smith
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

7.  Right heart catheterization in rats with pulmonary hypertension and right ventricular hypertrophy.

Authors:  H G Zimmer; W Zierhut; R C Seesko; A E Varekamp
Journal:  Basic Res Cardiol       Date:  1988 Jan-Feb       Impact factor: 17.165

8.  Hypoxic cardiac hypertrophy is not inhibited by cardioselective or non-selective beta-adrenoceptor antagonists.

Authors:  P Dennis; E M Vaughan Williams
Journal:  J Physiol       Date:  1982-03       Impact factor: 5.182

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.